MarketScreener Homepage > Equities > Australian Stock Exchange > Sigma Healthcare Limited SIG AU000000SIG5

Report

End-of-day quote Australian Stock Exchange - 01/15
0.615	AUD		0.00%

2020

SIGMA HEALTHCARE : Change of Director's Interest Notice

2020

SIGMA HEALTHCARE : Updated Share Trading Policy

2020

SIGMA HEALTHCARE : Statement

Summary

Financials

Sales 2021	3 429 M 2 642 M 2 642 M
Net income 2021	21,5 M 16,5 M 16,5 M
Net Debt 2021	143 M 110 M 110 M
P/E ratio 2021	28,0x
Yield 2021	0,72%

Sales 2022	3 536 M 2 724 M 2 724 M
Net income 2022	35,8 M 27,6 M 27,6 M
Net Debt 2022	138 M 107 M 107 M
P/E ratio 2022	17,9x
Yield 2022	4,18%

Capitalization	607 M 468 M 468 M
EV / Sales 2021	0,22x
EV / Sales 2022	0,21x
Nbr of Employees	1 900
Free-Float	-

More Financials

Company

Sigma Company Limited is engaged in the manufacture, marketing and wholesale distribution of pharmaceutical and allied products through the pharmacy and grocery channels, and the provision of services to retail pharmacists in Australia. The pharmaceutical division is a contract manufacturer for Australian and international pharmaceutical companies. It is also engaged in the manufacture and marketing of...

Sector

Food Processing

Calendar

03/23

Ergebnisveröffentlichung

More about the company

Notations Surperformance© of Sigma Healthcare Limited

Trading Rating :

Investor Rating :

More Ratings

All news about SIGMA HEALTHCARE LIMITED

2020	SIGMA HEALTHCARE : Change of Director's Interest Notice	PU
2020	SIGMA HEALTHCARE : Updated Share Trading Policy	PU
2020	SIGMA HEALTHCARE : Statement	PU
2020	SIGMA HEALTHCARE : Change of Director's Interest Notice	PU
2020	SIGMA HEALTHCARE : Citi Group Investor conference presentation	PU
2020	SIGMA HEALTHCARE : Change of Director's Interest Notice	PU
2020	SIGMA HEALTHCARE : Change of Director's Interest Notice	PU
2020	SIGMA HEALTHCARE : Appointment of Chief Financial Officer	PU
2020	SIGMA HEALTHCARE : Change of Director's Interest Notice	PU
2020	SIGMA HEALTHCARE : Appendix 4D- Half Year Financial Report	PU
2020	SIGMA HEALTHCARE : Half Year 2020/21 ASX Release	PU
2020	SIGMA HEALTHCARE : Half Year 2020/21 Results Presentation	PU
2020	SIGMA HEALTHCARE : Half Year Results Briefing Details	PU
2020	SIGMA HEALTHCARE : Change in substantial holding	PU
2020	SIGMA HEALTHCARE : sells two Distribution Centres for $172m	PU

More news

News in other languages on SIGMA HEALTHCARE LIMITED

2018	SIGMA HEALTHCARE LTD : Veröffentlichung des Halbjahresergebnisses
2018	SIGMA HEALTHCARE LTD : publication des résultats semestriels
2018	SIGMA HEALTHCARE LTD : Veröffentlichung des Jahresergebnisses
2018	SIGMA HEALTHCARE LTD : publication des résultats annuels

More news

Provided by Scoopnest.com

Chart SIGMA HEALTHCARE LIMITED

Duration : Period :

Sigma Healthcare Limited Technical Analysis Chart | MarketScreener

Full-screen chart

Technical analysis trends SIGMA HEALTHCARE LIMITED

	Short Term	Mid-Term	Long Term
Trends	Bullish	Neutral	Neutral

Technical analysis

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	OUTPERFORM
Number of Analysts	7
Average target price	0,68 AUD
Last Close Price	0,62 AUD
Spread / Highest target	22,0%
Spread / Average Target	10,1%
Spread / Lowest Target	-2,44%

Consensus

EPS Revisions

More Estimates Revisions

Managers and Directors

Name	Title
Mark Robert Hooper	Chief Executive Officer, Executive Director & MD
Raymond Mark Gunston	Non-Executive Chairman
Richard Church	Executive General Manager-Operations
Jackie Pearson	Chief Financial Officer
Martin Hawkins	Chief Information Officer

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

SIGMA HEALTHCARE LIMITED	0.00%	468



BY-HEALTH CO., LTD.	-1.95%	5 778
BALCHEM CORPORATION	6.01%	3 952
THE SIMPLY GOOD FOODS COMPANY	-10.71%	2 680
MEDIFAST, INC.	9.91%	2 444
BIOGAIA AB (PUBL)	-6.15%	1 216

More Results